Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
PHASE1
Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment ...
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
PHASE3
The objective of this study is to evaluate the safety and efficacy of the c...
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
PHASE3
The purpose of this study is to evaluate the safety and efficacy of ABT-335...